Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.
about
Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement.Accepting the challenge: maintaining AJP-Lung as the best place to publish basic and translational studies in lung biology and pathophysiology.
P2860
Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.
@ast
Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.
@en
Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.
@nl
type
label
Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.
@ast
Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.
@en
Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.
@nl
prefLabel
Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.
@ast
Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.
@en
Biomarkers of Exposure to New and Emerging Tobacco and Nicotine Delivery Products.
@nl
P2093
P2860
P1476
Biomarkers of exposure to new and emerging tobacco delivery products
@en
P2093
Ahmad El Hellani
Arunava Ghosh
Aruni Bhatnagar
Benjamin C Blount
Claire M Doerschuk
Clementina Mesaros
Gideon St Helen
Heather L Kimmel
Ian A Blair
Jessica R Martin
P2860
P304
P356
10.1152/AJPLUNG.00343.2016
P577
2017-05-18T00:00:00Z